angiogenic and t-effector subgroups and propensity for pbrm1 and bap1 alterations in ccrcc
Published 3 years ago • 95 plays • Length 5:30Download video MP4
Download video MP3
Similar videos
-
2:13
eter100: benmelstobart and anlotinib in advanced renal cell carcinoma
-
0:45
histo-genetic risk classification in renal cell carcinoma
-
2:03
angiogenesis subtypes and related differential methylation in renal clear cell carcinoma
-
5:57
pbrm1 as a biomarker for renal cell carcinoma
-
1:54
pd-l1 and other biomarkers for renal cell carcinoma
-
0:45
altogen biosystems aspc1 transfection reagent
-
2:26
best of eau23: renal cancer
-
0:41
dr. pal on molecular signatures in renal cell carcinoma
-
1:07
egr1 as a prognostic biomarker in enktl
-
1:24
kd033, a pdl1-1l15 bispecific molecule for the treatment of cancer
-
11:30
single cell genomics in breast cancer: breast tumour evolution and intra-tumour heterogeneity
-
9:57
cd91 on antigen-presenting cells influences response to nascent tumors
-
38:46
a multi-omic single cell and spatial atlas of breast cancer reveals stromal suppression
-
13:37
oncogenic sequencing in uveal melanoma cell lines - dr john park
-
1:12
dr. markman on the search for actionable biomarkers in ovarian cancer
-
2:53
comparison of three different pd-l1 diagnostic tests shows a high degree of concordance
-
1:39
using single cell technologies to identify biomarkers for breast cancer patient outcomes
-
0:54
what is unclassified renal cell carcinoma?
-
0:56
pembrolizumab and the significance of pd-l1 for lung cancer